Cfo4 Life Group, LLC Edwards Lifesciences Corp Transaction History

Cfo4 Life Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $338,256 - $415,562	-3,180 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$102.91 - $122.75 $30,873 - $36,825	300 Added 10.42%	3,180 $360,000
Q3 2020 Oct 13, 2020	BUY	$67.19 - $87.44 $193,507 - $251,827	2,880 New	2,880 $230,000
Q1 2020 Apr 16, 2020	SELL	$52.41 - $81.0 $50,313 - $77,760	-960 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$61.55 - $75.43 $59,088 - $72,412	960 New	960 $211,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Cfo4 Life Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cfo4 Life Group, LLC with notifications on news.